These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37404381)

  • 1. Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn's Disease.
    Asonuma K; Kobayashi T; Kikkawa N; Nakano M; Sagami S; Morikubo H; Miyatani Y; Hojo A; Fukuda T; Hibi T
    Inflamm Intest Dis; 2023; 8(1):13-22. PubMed ID: 37404381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein.
    Hiraga H; Chinda D; Hasui K; Murai Y; Maeda T; Higuchi N; Ogasawara K; Kudo S; Sawada Y; Tatsuta T; Kikuchi H; Ebina M; Hiraga N; Mikami T; Sakuraba H; Fukuda S
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn's Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
    Matsumoto S; Mashima H
    Crohns Colitis 360; 2023 Jul; 5(3):otad028. PubMed ID: 37288327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.
    Kawamura T; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Iida T; Mizutani Y; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M
    Inflamm Bowel Dis; 2023 Feb; 29(2):245-253. PubMed ID: 35436345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn's Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy.
    Omori T; Sasaki Y; Koroku M; Murasugi S; Yonezawa M; Nakamura S; Tokushige K
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
    Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.
    Abe I; Shiga H; Chiba H; Miyazawa T; Oomori S; Shimoyama Y; Moroi R; Kuroha M; Kakuta Y; Kinouchi Y; Masamune A
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1741-1748. PubMed ID: 35641439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn's Disease.
    Saiki T; Torisu T; Harada A; Kajiya Y; Taniguchi Y; Morisaki S; Umeno J; Suekane H; Kitazono T
    Inflamm Intest Dis; 2023 Oct; 8(2):69-76. PubMed ID: 37901342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine-Rich Alpha-2 Glycoprotein in Monitoring Disease Activity and Intestinal Stenosis in Inflammatory Bowel Disease.
    Yoshida T; Shimodaira Y; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Tohoku J Exp Med; 2022 Jul; 257(4):301-308. PubMed ID: 35598974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of leucine-rich alpha-2-glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients.
    Ito T; Dai K; Horiuchi M; Horii T; Furukawa S; Maemoto A
    JGH Open; 2023 Sep; 7(9):645-651. PubMed ID: 37744712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.
    Yasutomi E; Inokuchi T; Hiraoka S; Takei K; Igawa S; Yamamoto S; Ohmori M; Oka S; Yamasaki Y; Kinugasa H; Takahara M; Harada K; Furukawa M; Itoshima K; Okada K; Otsuka F; Tanaka T; Mitsuhashi T; Kato J; Okada H
    Sci Rep; 2021 May; 11(1):11086. PubMed ID: 34045529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopy.
    Kawamoto A; Takenaka K; Hibiya S; Kitazume Y; Shimizu H; Fujii T; Saito E; Ohtsuka K; Okamoto R
    Intest Res; 2024 Jan; 22(1):65-74. PubMed ID: 37939721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin predicts endoscopic activity and mucosal healing of small bowel Crohn's disease evaluated by double-balloon endoscopy.
    Han W; Wu J; Zhang P; Hu N; Mei Q; Hu J
    Int J Colorectal Dis; 2022 Sep; 37(9):1953-1961. PubMed ID: 35927341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity.
    Zittan E; Kelly OB; Gralnek IM; Silverberg MS; Hillary Steinhart A
    JGH Open; 2018 Oct; 2(5):201-206. PubMed ID: 30483590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
    Shinzaki S; Matsuoka K; Tanaka H; Takeshima F; Kato S; Torisu T; Ohta Y; Watanabe K; Nakamura S; Yoshimura N; Kobayashi T; Shiotani A; Hirai F; Hiraoka S; Watanabe M; Matsuura M; Nishimoto S; Mizuno S; Iijima H; Takehara T; Naka T; Kanai T; Matsumoto T
    J Gastroenterol; 2021 Jun; 56(6):560-569. PubMed ID: 33942166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
    Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: A multicenter study in Japan.
    Yasuda R; Arai K; Kudo T; Nambu R; Aomatsu T; Abe N; Kakiuchi T; Hashimoto K; Sogo T; Takahashi M; Etani Y; Kato K; Yamashita Y; Mitsuyama K; Mizuochi T
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1131-1139. PubMed ID: 36880154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
    Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.
    Takenaka K; Kitazume Y; Kawamoto A; Fujii T; Udagawa Y; Wanatabe R; Shimizu H; Hibiya S; Nagahori M; Ohtsuka K; Sato H; Hirakawa A; Watanabe M; Okamoto R
    Am J Gastroenterol; 2023 Jun; 118(6):1028-1035. PubMed ID: 36571769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
    Shinzaki S; Matsuoka K; Iijima H; Mizuno S; Serada S; Fujimoto M; Arai N; Koyama N; Morii E; Watanabe M; Hibi T; Kanai T; Takehara T; Naka T
    J Crohns Colitis; 2017 Jan; 11(1):84-91. PubMed ID: 27466171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.